Skip to main content
William Cefalu, MD, Endocrinology, New Orleans, LA

WilliamThomasCefaluMD

Endocrinology • New Orleans, LA

Diabetes, Lipid Metabolism

Professor, Section of Endocrinolgy, Diabetes and Metabolism, LSUHSC; Director, Joint Diabetes, Endocrinology and Metabolism Program, LSUHSC & Pennington Biomedical Research Center; Vice-Chair, Clinical Research, Department of Medicine, LSUHSC; Director, Allen A. Copping In-Patient Research Unit, PBRC; Director, NIH Center for the Study of Botanicals and Metabolic Syndrome, PBRC

Join to view full profile

Are you Dr. Cefalu?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 33 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. William Cefalu, MD is an endocrinologist in New Orleans, Louisiana. He is currently licensed to practice medicine in Louisiana, Vermont, and North Carolina. He is a Professor at Diabetes and Metabolism.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1982 - 1986
  • University of California (Irvine)
    University of California (Irvine)Residency, Internal Medicine, 1981 - 1982
  • Louisiana State University School of Medicine in New Orleans
    Louisiana State University School of Medicine in New OrleansClass of 1980

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1981 - Present
  • LA State Medical License
    LA State Medical License 1979 - 2024
  • VT State Medical License
    VT State Medical License 1998 - 2010
  • NC State Medical License
    NC State Medical License 1988 - 1998
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Loss-of-Function Mutation in Thiamine Transporter 1 in a Family with Autosomal Dominant Diabetes
    Loss-of-Function Mutation in Thiamine Transporter 1 in a Family with Autosomal Dominant DiabetesMarch 4th, 2020
  • ASMBS Annual Meeting at ObesityWeek 2019
    ASMBS Annual Meeting at ObesityWeek 2019December 1st, 2019
  • AgeX Therapeutics to Present at Metabesity 2019
    AgeX Therapeutics to Present at Metabesity 2019October 11th, 2019
  • Join now to see all

Grant Support

  • Pregnane And Glycosides And Obesity/Llya RaskinNational Center For Complementary &Alternative Medicine2010–2011
  • Integrative Biology Core/Thomas W. GettysNational Center For Complementary &Alternative Medicine2010–2011
  • Botanical Research Core/David M. RibnickyNational Center For Complementary &Alternative Medicine2010–2011
  • Artemisia SP And Insulin Action/William T. CefaluNational Center For Complementary &Alternative Medicine2010–2011
  • Adipocytes And Botanicals/Jacequeline M. StephensNational Center For Complementary &Alternative Medicine2010–2011
  • Botanicals And Metabolic SyndromeNational Center For Complementary &Alternative Medicine2005–2011
  • Pmi-5011 And Insulin ActionNational Center For Complementary &Alternative Medicine2005–2009
  • Chromium, Cellular Energy Status And Whole Body Energy BalanceNational Center For Complementary &Alternative Medicine2006–2007
  • Administrative CoreNational Center For Complementary &Alternative Medicine2005–2007
  • Chromium And Insulin ActionNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2006
  • Chromium, Cellular Energy Status, Whole Body Energy BalaNational Center For Complementary &Alternative Medicine2005
  • HRT To Augment Loss Of Visceral Fat And Improve Insulin SensitivityNational Center For Research Resources2004–2005
  • Effect Of Chromium Picolinate On Glucose Control In Type II Diabetic PatientsNational Center For Research Resources2004
  • Chromium VS Factors Regulating Insulin Sensitivity In Type 2 DiabetesNational Center For Research Resources2004
  • Changes In Body COMP. &Insulin Sens. On Cardiovascular Risk In Type 2 DiabetesNational Center For Research Resources2004
  • Hormone Replacement For Prevention Of Visceral ObesityNational Institute On Aging2001–2002
  • Effect Of Chromium Picolinate On Glucose Control In Type 2 Diabetic PatientsNational Center For Research Resources1999–2002
  • Chromium And Insulin ActionNational Institute Of Diabetes And Digestive And Kidney Diseases2001
  • Caloric Restriction, Aging, And Insulin ActionNational Institute On Aging1999–2001
  • Comparison Of Glucotrol And Metformin Alone And Combined In Patients With NIDDMNational Center For Research Resources1997–2000
  • Inhaled Human Insulin VS Usual SQ Insulin In Type II Diabetes MellitusNational Center For Research Resources1998–1999
  • Inhaled Human Insulin VS Usual SQ Insulin In Type I Diabetes MellitusNational Center For Research Resources1998–1999
  • Inhaled Human Insulin As Adjunctive Therapy In Subjects With Type 2 DiabetesNational Center For Research Resources1998–1999
  • Nutritional Modulation Of Age Related ProcessesNational Center For Research Resources1996–1999
  • Caloric Restriction, Aging And Cardiovascular DiseaseNational Institute On Aging1993–1998
  • Caloric Restriction, Aging And Cardiovascular DiseaseNational Institute On Aging1997
  • Norvasc As Alternate Therapy To Procardia XL Of Essential HypertensionNational Center For Research Resources1996–1997
  • Effect Of Sulfonylurea On Tissue Sensitivity To Insulin In Diabetes MellitusNational Center For Research Resources1994–1997
  • Comparison Trial Of Effects Of Estrogen And Hormone Replacement TherapyNational Center For Research Resources1994–1996
  • Caloric Restriction And Cardiovascular AgingNational Institute On Aging1992–1996

Dr. William Cefalu, Dr. William Cefalu, MD, Dr. W Cefalu, Dr. William Thomas Cefalu